Literature DB >> 1308373

Long-acting local anesthetics in dentistry.

A L Sisk1.   

Abstract

Long-acting local anesthetics have proved to be effective for the suppression of both intraoperative and postoperative pain. They are useful for lengthy dental treatments and for prevention of severe pain following many types of surgical procedures. Although the currently available long-acting local anesthetics for dentistry have minimal side effects in the doses usually employed, there are potential problems. Bupivacaine, for example, can cause significant cardiac depressant and dysrhythmogenic responses. Etidocaine has less pronounced effects on the cardiovascular system, but its use may be associated with inadequate control of intraoperative bleeding. A new long-acting local anesthetic, ropivacaine, appears to offer advantages over either of the currently used long-acting agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1308373      PMCID: PMC2148750     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  59 in total

1.  Local anesthetic activity and acute toxicity of ( )-2-(N-ethylpropylamino)-2',6'-butyroxylidide, a new long-acting agent.

Authors:  H J Adams; G H Kronberg; B H Takman
Journal:  J Pharm Sci       Date:  1972-11       Impact factor: 3.534

2.  Binding of anilide-type local anesthetics in human plasma. I. Relationships between binding, physicochemical properties, and anesthetic activity.

Authors:  G T Tucker; R N Boyes; P O Bridenbaugh; D C Moore
Journal:  Anesthesiology       Date:  1970-09       Impact factor: 7.892

3.  Cardiovascular effects of convulsant and supraconvulsant doses of amide local anesthetics.

Authors:  R H de Jong; R A Ronfeld; R A DeRosa
Journal:  Anesth Analg       Date:  1982-01       Impact factor: 5.108

4.  Convulsions and ventricular tachycardia from bupivacaine with epinephrine: successful resuscitation.

Authors:  S R Mallampati; P L Liu; R M Knapp
Journal:  Anesth Analg       Date:  1984-09       Impact factor: 5.108

5.  Newer local anesthetics and techniques for administration.

Authors:  L P Gangarosa
Journal:  J Dent Res       Date:  1981-08       Impact factor: 6.116

6.  Ultralong-acting local anesthetic agents.

Authors:  B G Covino
Journal:  Anesthesiology       Date:  1981-04       Impact factor: 7.892

7.  Etidocaine HCl local anesthetic for periodontal flap surgery.

Authors:  G L Hlava; R A Reinhardt; K L Kalkwarf
Journal:  J Periodontol       Date:  1984-06       Impact factor: 6.993

8.  Comparison of the effectiveness of etidocaine and lidocaine as local anesthetic agents during oral surgery.

Authors:  W M Davis; J Oakley; E Smith
Journal:  Anesth Prog       Date:  1984 Jul-Aug

9.  Advantages of long-acting local anesthesia using etidocaine hydrochloride.

Authors:  O T Jensen; L G Upton; J R Hayward; R B Sweet
Journal:  J Oral Surg       Date:  1981-05

10.  Deaths from local anesthetic-induced convulsions in mice.

Authors:  R H de Jong; J D Bonin
Journal:  Anesth Analg       Date:  1980-06       Impact factor: 5.108

View more
  10 in total

1.  A Comparative Study Between Bupivacaine with Adrenaline and Carbonated Bupivacaine with Adrenaline for Surgical Removal of Impacted Mandibular Third Molar.

Authors:  M Shyamala; C Ramesh; V Yuvaraj; V Suresh; R SathyaNarayanan; T S Balaji; M Neil Dominic; B Nithin Joseph Jude
Journal:  J Maxillofac Oral Surg       Date:  2015-05-29

2.  Is amalgamated ligno-bupivacaine an answer to complicated minor oral surgical anesthesia? A randomized split-mouth double-blind clinical trial.

Authors:  Akshay Mishra; Monica Mahajan; Chandrashekhar Bande; Ajit Joshi; Mayur Gawande; M K Gupta
Journal:  Oral Maxillofac Surg       Date:  2018-01-23

3.  Double-blind, randomized controlled clinical trial on analgesic efficacy of local anesthetics articaine and bupivacaine after impacted third molar extraction.

Authors:  Maria Victoria Olmedo-Gaya; Francisco Javier Manzano-Moreno; Jose Luis Muñoz-López; Manuel Francisco Vallecillo-Capilla; Candela Reyes-Botella
Journal:  Clin Oral Investig       Date:  2018-02-15       Impact factor: 3.573

4.  Bupivacaine 0.5% versus articaine 4% for the removal of lower third molars. A crossover randomized controlled trial.

Authors:  Manuel Sancho-Puchades; Miguel-Ángel Vílchez-Pérez; Eduard Valmaseda-Castellón; Jordi Paredes-García; Leonardo Berini-Aytés; Cosme Gay-Escoda
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-05-01

5.  A prospective, randomized, triple-blind comparison of articaine and bupivacaine for maxillary infiltrations.

Authors:  M-A Vílchez-Pérez; M Sancho-Puchades; E Valmaseda-Castellón; J Paredes-García; L Berini-Aytés; C Gay-Escoda
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-03-01

6.  Comparative Analysis of the Anesthetic Efficacy of 0.5% Ropivacaine Versus 2% Lignocaine Hydrochloride with Adrenaline (1:80,000) for Inferior Alveolar Nerve Block in Surgical Removal of Impacted Mandibular Third Molars.

Authors:  Ram Goyal; Parveen Sharma; Rishi Bali
Journal:  J Maxillofac Oral Surg       Date:  2020-07-31

7.  Efficacy and safety of bupivacaine versus lidocaine in dental treatments: a meta-analysis of randomised controlled trials.

Authors:  Naichuan Su; Hang Wang; Shu Zhang; Shuang Liao; Shuying Yang; Yi Huang
Journal:  Int Dent J       Date:  2013-10-11       Impact factor: 2.607

8.  Comparative study of analgesia with bupivacaine 0.25% versus 0.5% for third molar removal under general anesthesia.

Authors:  Parmanand Dhanrajani; Patrick Chung
Journal:  J Dent Anesth Pain Med       Date:  2016-06-30

9.  Comparison of clinical efficacy of ropivacaine and lignocaine with adrenaline for implant surgery anesthesia: a split-mouth randomized controlled clinical trial.

Authors:  Remya Nath Kalath; Rithesh Kulal; Sharika Gopinath
Journal:  J Dent Anesth Pain Med       Date:  2021-07-30

10.  The Effectiveness of Ropivacaine and Mepivacaine in the Postoperative Pain after Third Lower Molar Surgery.

Authors:  Vito Crincoli; Gianfranco Favia; Luisa LImongelli; Angela Tempesta; Nicola Brienza
Journal:  Int J Med Sci       Date:  2015-10-16       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.